STOCK TITAN

Lifevantage Corporation - LFVN STOCK NEWS

Welcome to our dedicated page for Lifevantage Corporation news (Ticker: LFVN), a resource for investors and traders seeking the latest updates and insights on Lifevantage Corporation stock.

Lifevantage Corporation Common Stock (Delaware) (symbol: LFVN) is a pioneering company in the field of nutrigenomics, a cutting-edge area of nutritional science focused on how nutrients affect gene expression to improve health and wellness. Founded on the premise that aging is inevitable but can be managed, Lifevantage offers a range of products designed to combat the effects of aging and promote overall well-being.

The company's core business involves the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. Among its flagship offerings is Protandim, a scientifically-validated dietary supplement known for its ability to reduce oxidative stress. Other notable products include the LifeVantage TrueScience anti-aging skincare line, Axio energy drink mixes, PhysIQ weight management systems, and Canine Health, a pet supplement formulated to improve the health of dogs.

Lifevantage's products are available in multiple regions, including the United States, Japan, Hong Kong, Australia, Canada, the Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands. This geographical diversification helps the company reach a broad audience and sustain its growth trajectory.

Recently, Lifevantage has made significant strides in its business operations. Hundreds of independent consultants hosted virtual watch parties to kickstart the company's initiatives for 2024. The company also continues to innovate, as seen in the second quarter of fiscal 2024 results and the upcoming launch of its Evolve Compensation Plan and Rewards Circle customer loyalty program on February 1, 2024. These initiatives are designed to enhance customer satisfaction and drive business growth.

Financially, Lifevantage is committed to transparency and accountability, regularly updating investors on its performance through detailed reports and investor relations contacts. Despite the challenges posed by COVID-19, the company has maintained a resilient stance, focusing on future growth and product expansion.

Overall, Lifevantage remains a significant player in the health and wellness industry, continually advancing the science of nutrigenomics to offer effective solutions for aging and other health-related concerns.

Rhea-AI Summary
LifeVantage urges stockholders to vote 'FOR' its highly engaged directors on the WHITE Universal Proxy Card
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.23%
Tags
none
-
Rhea-AI Summary
Radoff-Sudbury Group believes LifeVantage needs new perspectives in the boardroom
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.85%
Tags
none
-
Rhea-AI Summary
LifeVantage announces successful conclusion of annual Global Convention
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.77%
Tags
none
Rhea-AI Summary
LifeVantage Corporation releases letter from directors expressing support for targeted directors
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
none
-
Rhea-AI Summary
LifeVantage highlights progress with LV360 plan, outperforming market index by 71.9% and peer median by 82.9%. Balanced capital allocation strategy includes share repurchases, regular dividends, and special dividend. Board urges stockholders to vote 'FOR' LifeVantage's seven highly qualified director candidates. The Radoff-Sudbury Group seeks outsized board representation and threatens to replace highly qualified directors with inferior candidates. LifeVantage continues to execute on LV360 plan, delivering value to stockholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.92%
Tags
none
-
Rhea-AI Summary
LifeVantage to participate in H.C. Wainwright 25th Annual Global Investment Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.1%
Tags
conferences
Rhea-AI Summary
LifeVantage adopts limited duration stockholder rights plan to protect long-term interests and value of investment
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.37%
Tags
none
-
News
Rhea-AI Summary
LifeVantage Corporation approves quarterly cash dividend of $0.035 per share of common stock.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
23.88%
Tags
dividends
-
Rhea-AI Summary
LifeVantage Corporation reports Q4 revenue of $54.2 million, a 6.4% increase YoY. Americas revenue increased 17.9% while Asia/Pacific & Europe revenue decreased 16.0%. Total active accounts declined 8.3%. Net income per diluted share was $0.15, compared to a loss of $0.11 a year ago. Adjusted EBITDA was $4.8 million, compared to $1.7 million a year ago. Fiscal year 2023 revenue increased 3.4% to $213.4 million. Americas revenue increased 12.3% while Asia/Pacific & Europe revenue decreased 14.7%. Earnings per diluted share were $0.20, compared to $0.24 in fiscal 2022. Adjusted EBITDA was $11.7 million, compared to $12.8 million in fiscal 2022. The company declares a special cash dividend of $0.40 per share and expects revenue in the range of $216 million to $226 million in fiscal year 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
23.88%
Tags
Rhea-AI Summary
LifeVantage Corporation announces special one-time cash dividend of $0.40 per share of common stock
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
23.88%
Tags
dividends

FAQ

What is the current stock price of Lifevantage Corporation (LFVN)?

The current stock price of Lifevantage Corporation (LFVN) is $17.36 as of December 20, 2024.

What is the market cap of Lifevantage Corporation (LFVN)?

The market cap of Lifevantage Corporation (LFVN) is approximately 222.3M.

What does Lifevantage Corporation do?

Lifevantage Corporation specializes in nutrigenomics, researching and developing dietary supplements and skincare products to improve health and combat aging.

What are some of the key products offered by Lifevantage?

Lifevantage offers products such as Protandim, LifeVantage TrueScience skincare, Axio energy drinks, PhysIQ weight management systems, and Canine Health supplements.

In which regions are Lifevantage's products sold?

Lifevantage products are sold in the United States, Japan, Hong Kong, Australia, Canada, the Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

What recent achievements has Lifevantage made?

Lifevantage recently hosted successful virtual watch parties for 2024 and is launching the Evolve Compensation Plan and Rewards Circle loyalty program in February 2024.

How does Lifevantage contribute to the field of nutrigenomics?

Lifevantage is at the forefront of nutrigenomics, using scientific research to develop products that improve health by affecting gene expression.

What is Protandim?

Protandim is a scientifically-validated dietary supplement from Lifevantage, known for its ability to reduce oxidative stress.

How does Lifevantage support its investors?

Lifevantage maintains transparency with regular financial updates and investor relations contacts to keep investors informed about the company's performance.

What challenges has Lifevantage faced recently?

Lifevantage, like many other companies, has faced challenges from the COVID-19 pandemic but continues to focus on growth and product expansion.

Who should use Lifevantage products?

Lifevantage products are designed for individuals seeking to improve their health, manage aging, and enhance overall wellness, including pet owners with its Canine Health supplement.

What is the Evolve Compensation Plan?

The Evolve Compensation Plan is an initiative by Lifevantage set to launch in February 2024, aimed at enhancing customer satisfaction and loyalty.

Lifevantage Corporation

Nasdaq:LFVN

LFVN Rankings

LFVN Stock Data

222.26M
10.24M
16.9%
37.13%
1.77%
Packaged Foods
Pharmaceutical Preparations
Link
United States of America
LEHI